Insider Selling: HealthEquity (NASDAQ:HQY) EVP Sells $298,490.00 in Stock

HealthEquity, Inc. (NASDAQ:HQY) EVP Michael Henry Fiore sold 3,142 shares of the business’s stock in a transaction on Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the completion of the sale, the executive vice president directly owned 59,113 shares of the company’s stock, valued at approximately $5,615,735. The trade was a 5.05% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $86.00 on Friday. The firm has a market cap of $7.19 billion, a PE ratio of 32.21, a PEG ratio of 1.46 and a beta of 0.21. The firm has a fifty day moving average of $83.93 and a 200 day moving average of $86.31. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. HealthEquity, Inc. has a one year low of $72.76 and a one year high of $116.65.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The company had revenue of $354.64 million during the quarter, compared to analyst estimates of $352.02 million. The company’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, research analysts predict that HealthEquity, Inc. will post 3.86 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the company. Sivia Capital Partners LLC acquired a new position in HealthEquity in the second quarter valued at about $306,000. Arrowstreet Capital Limited Partnership acquired a new position in HealthEquity in the second quarter valued at about $4,747,000. Marshall Wace LLP acquired a new position in HealthEquity in the second quarter valued at about $5,483,000. Amundi lifted its position in HealthEquity by 9.3% in the second quarter. Amundi now owns 30,203 shares of the company’s stock valued at $3,059,000 after buying an additional 2,574 shares during the last quarter. Finally, Jump Financial LLC acquired a new position in HealthEquity in the second quarter valued at about $449,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

HQY has been the subject of a number of research reports. UBS Group set a $110.00 target price on shares of HealthEquity in a report on Tuesday, February 17th. KeyCorp reaffirmed an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. JPMorgan Chase & Co. dropped their target price on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating for the company in a report on Wednesday, March 18th. Deutsche Bank Aktiengesellschaft upped their target price on shares of HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a report on Thursday, March 19th. Finally, Barclays lowered their price target on shares of HealthEquity from $118.00 to $110.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 18th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $110.57.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.